Moolec Science SA (MLEC)
NASDAQ: MLEC · Real-Time Price · USD
0.850
-0.010 (-1.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
Moolec Science SA, a science-based food ingredient company, focuses on developing ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology.
It develops textured soy proteins, safflower oil, meat replacement products, food ingredients, and nutritional supplements.
It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Moolec Science SA
Country | Luxembourg |
Founded | 2008 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 52 |
CEO | Gaston Paladini |
Contact Details
Address: 17, Boulevard F.W. Raiffeisen Luxembourg, 2411 Luxembourg | |
Phone | 352 26 49 65 65 |
Website | moolecscience.com |
Stock Details
Ticker Symbol | MLEC |
Exchange | NASDAQ |
Fiscal Year | July - June |
Reporting Currency | USD |
CIK Code | 0001937737 |
ISIN Number | LU2559000059 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Gaston Paladini M.B.A. | Co-Founder, Chief Executive Officer and Director |
Henk Hoogenkamp Ph.D. | Co-Founder and Chief Product Officer |
Martin Salinas Ph.D. | Chief of Technology and Co-Founder |
Jose Lopez Lecube M.B.A. | Chief Financial Officer and Director |
Dr. Amit Dhingra Ph.D. | Chief Science Officer |
Florencia Bottero | Corporate Counsel and Secretary of the Board |
Catalina Jones B.A. | Chief of Staff and Sustainability |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 20, 2024 | 424B3 | Prospectus |
Dec 13, 2024 | 6-K | Report of foreign issuer |
Dec 6, 2024 | 424B3 | Prospectus |
Nov 26, 2024 | EFFECT | Notice of Effectiveness |
Nov 26, 2024 | 424B3 | Prospectus |
Nov 25, 2024 | POS AM | Post-Effective amendments for registration statement |
Nov 19, 2024 | EFFECT | Notice of Effectiveness |
Nov 15, 2024 | UPLOAD | Filing |
Nov 12, 2024 | F-3 | Filing |
Oct 30, 2024 | 20-F | Annual and transition report of foreign private issuers |